diff --git a/Cod-Liver-Oil.md b/Cod-Liver-Oil.md
new file mode 100644
index 0000000..03905b8
--- /dev/null
+++ b/Cod-Liver-Oil.md
@@ -0,0 +1,3 @@
+<br> On April 20, 2000, Judge John Gleeson entered a preliminary injunction ordering Vale and Christian Bros., through the pendency of the civil go well with, to not straight or indirectly promote, distribute, package deal, label, or promote Laetrile, often known as amygdalin, "Vitamin B-17," or apricot pits. On November 16, 2000, Judge Gleeson ended the civil suit by completely ordering Vale and Christian Bros. District Court Judge Robert J. Vining, Jr. entered a Consent Decree of Permanent Injunction enjoining Hi-Tech Pharmaceuticals,  [stefactory.pro](https://stefactory.pro/?attachment_id=10043/feed) National Urological Group, National Institute for Clinical Weight reduction,  [119.45.169.144](http://119.45.169.144:3000/cesaresteban8/2135701/wiki/What%2527s+Blood+Glucose%253F) American Weight reduction Clinic, United Metabolic Research Center, and Jared R. Wheat, President of these firms, from distributing unapproved new medicine and misbranded drugs. Earlier in June 2003, FDA had issued a "Public Health Alert" warning shoppers not to [buy Gluco Extend](http://210.22.83.206:3000/gladisdimattia/gluco-extend-official1994/wiki/Diabetes-Friendly-Snacks:-Q0-Tasty-Options-For-Blood-Sugar-Control) or devour sure dietary supplements offered by Hi-Tech Pharmaceuticals, Inc. and associated company, National Urological Group, as a result of FDA take a look at outcomes found the supplements were adulterated with the prescription-energy drug ingredient "taldalafil." An interplay between certain prescription medicine containing nitrates (equivalent to nitroglycerin) and taldalafil may cause a drastic reducing of blood strain. Its principal energetic ingredient is ephedrine, which when chemically synthesized is regulated as a drug.<br>
+
+<br> FDA is aware that some road drug alternatives are being marketed as dietary supplements. At the identical time, FDA requested public comment on new proof of well being risks associated with ephedra
\ No newline at end of file